+
Site Tour

LAAO 2023: What's new – Trends and recent data for LAA occlusion therapies

Boris Schmidt presents a short summary of the most recent data on left atrial appendage occlusion from the last 18 months.

Related Videos

LAAO Summit 2023: LAAO device

LAAO Summit 2023: CT

LAAO Summit 2023: Leaks/DRT

LAAO Summit 2023: What's new – Q&A

LAAO Summit 2023: Complications

Review the Trends | Mitral focus

LAAO Summit - Decoding DRT patient factors

Case Transmission | Tricuspid focus

PremiClose 2024: Beside PDA closure

SAFETY IS A JOURNEY | M. Swaans & G. Leurent

Pre-term PDA cases

PremiClose 2024: The PDA, when to intervene

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Case Parade | Tricuspid focus

Case Parade | Tricuspid focus

M. Sitges, R. Estevez, V. Ninios, E. L. Heng, X. Freixa, W. Wojakowski, C. Besler

CONNEXT


TV
RELATED RESOURCES

AV Valves Summit 2024 | Closing of Day 1

Review the Trends | Mitral focus

LAAO Summit - New data & future trials

TAVI with Navitor Vision - Livecase

CONNEXT


HUB
RELATED RESOURCES

Nephrologist LAA Therapy Deck

Amulet IDE Results

Amplatzer™ Septal Occluder (ASO) technical brochure

PDL Analysis Summary

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline